More articles from Editorial
- Cox - 2 Inhibitors and Cardiovascular Risk
Even if we do not know with certainty whether COX-2 inhibitors increase the risk of cardiovascular events, we need to incorporate this concern into our practice.
- Handheld computers in medicine: The future is not here yet
Some problems need to be overcome before handheld computers become essential equipment in every physician’s pocket.
- Evidence of smoke and atherosclerotic fire
Why it is premature to extend the clinical use of the highly sensitive CRP assay as a test for coronary disease.
- C-reactive protein elevation can be caused by conditions other than inflammation and may reflect biologic aging
CRP elevations are a sensitive test for inflammation, hut are not specific.
- Who wants to be a health care worker? The health care staffing crisis
Unless we restore respect to the health care professions, we will soon face a serious shortage of physicians and nurses.
- If it ain’t broke, what are we trying to fix? Reprocessing devices labeled“for single use only”
A new FDA rule will enrich the manufacturers of medical devices and saddle us with another layer of bureaucracy. All to fix a nonexistent problem.
- Enthusiasm for ultrasound for osteoporosis screening is premature
Ultrasound shows promise for osteoporosis screening, but before the medical community embraces it, many questions need to be answered.
- The cruel “cancer cure” hype
The unrealistic hopes raised by recent news reports of an impending cure for cancer were cruel to patients.
- Some perspective on Viagramania
The sales of Viagra are not surprising, given that the search for a drug to enhance sexual performance is as old as written history.